Mf. Vincent et al., SUBSTRATE CYCLING BETWEEN 5-AMINO-4-IMIDAZOLECARBOXAMIDE RIBOSIDE ANDITS MONOPHOSPHATE IN ISOLATED RAT HEPATOCYTES, Biochemical pharmacology, 52(7), 1996, pp. 999-1006
AICA (5-amino-4-imidazolecarboxamide)-riboside is taken up by isolated
rat hepatocytes and converted by adenosine kinase (ATP:adenosine 5'-p
hosphotransferase, EC 2.7.1.20) into AICAR (ZMP), an intermediate of t
he de novo synthesis of purine nucleotides. We investigated ii, in the
se cells, a cycle analogous to the adenosine-AMP substrate cycle opera
tes between AICAriboside and ZMP. When 50 mu M ITu, an inhibitor of ad
enosine kinase, was added to hepatocytes that had metabolized AICAribo
side for 30 min, the concentration of ZMP decreased immediately. This
was mirrored by a reincrease of AICAriboside. Rates of the ITu-induced
decrease of ZMP and the increase of AICAriboside, calculated at diffe
rent concentrations of ZMP, were first order, up to the highest concen
tration of ZMP (approx. 5 mu mol/g of cells). Dephosphorylation of ZMP
added to crude cytosolic extracts of rat liver displayed hyperbolic k
inetics, with a V-max of 0.65 mu mol/min per g protein and an apparent
K-m of 5 mM, and was markedly inhibited by Pi, an inhibitor of IMP-GM
P 5'-nucleotidase (5'-ribonucleotide phosphohydrolase, EC 3.1.3.5). We
conclude that hepatocyte ZMP is continuously dephosphorylated, most l
ikely by IMP-GMP 5'-nucleotidase, into AICAriboside, which is rephosph
orylated into ZMP by adenosine kinase. Substrate cycling was also show
n to occur between other nucleoside analogs and their phosphorylated c
ounterparts.